GEMAROMA Gem Aromatics Q4 FY26 results (Jan–Mar 2026) and concall
Gem Aromatics Limited reported a quarter of sequential improvement in Q4 FY26, with significant QoQ growth in revenue and EBITDA, driven by better volumes and price realization. The company commenced commercial production at its new Dahej facility and achieved a high sustainability rating for its Silvassa plant. However, geopolitical issues caused delays in phenol derivative production, and U.S. tariffs led to a year-on-year decline in Q4 revenues for mint exports, impacting overall performance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 45.4%, net profit down 96.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 112 | 97 | 202 | 88 | 90 −20% | 79 −19% | 110 −45% |
| EBITDA | 15 | 13 | 46 | 15 | 3 −80% | 7 −46% | 16 −66% |
| Net profit | 10 | 7 | 28 | 8 | -3 −126% | -5 −167% | 1 −96% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
